boinet: An R Package for Bayesian Optimal Interval Design for Dose Finding Based on Both Efficacy and Toxicity Outcomes
Bayesian optimal interval based on both efficacy and toxicity outcomes (BOIN-ET) design is a model-assisted oncology phase I/II trial design, aiming to establish an optimal biological dose accounting for efficacy and toxicity in the framework of dose-finding. Some extensions of BOIN-ET design are also available to allow for time-to-event efficacy and toxicity outcomes based on cumulative and pending data (time-to-event BOIN-ET: TITE-BOIN-ET), ordinal graded efficacy and toxicity outcomes (generalized BOIN-ET: gBOIN-ET), and their combination (TITE-gBOIN-ET). The R package boinet implements the BOIN-ET design family. The package supports the conduct of simulation studies to assess operating characteristics of BOIN-ET, TITE-BOIN-ET, gBOIN-ET, and TITE-gBOIN-ET designs, where users can choose design parameters in flexible and straightforward ways depending on their own application. We demonstrate its capability and effectiveness using several simulation studies.
Institutions
- Center for Global Development (US)
- Astellas Pharma (Japan) (JP)
- University of Tsukuba (JP)
Publication Details
- Journal
- The R Journal
- Published
- 2025-09-23
- DOI
- https://doi.org/10.32614/rj-2025-012
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00